XTBG OpenIR  > 文献共享
Pharmacological Regulation of In Situ Tissue Stem Cells Differentiation for Soft Tissue Calcification Treatment
Hu, JJ; Yin, Z; Shen, WL; Xie, YB; Zhu, T; Lu, P; Cai, YZ; Kong, MJ; Heng, BC; Zhou, YT; Chen, WS; Chen, X; Ouyang, HW
2016
Source PublicationSTEM CELLS
ISSN1066-5099
Volume34Issue:4Pages:1083-1096
AbstractCalcification of soft tissues, such as heart valves and tendons, is a common clinical problem with limited therapeutics. Tissue specific stem/progenitor cells proliferate to repopulate injured tissues. But some of them become divergent to the direction of ossification in the local pathological microenvironment, thereby representing a cellular target for pharmacological approach. We observed that HIF-2alpha (encoded by EPAS1 inclined form) signaling is markedly activated within stem/progenitor cells recruited at calcified sites of diseased human tendons and heart valves. Proinflammatory microenvironment, rather than hypoxia, is correlated with HIF-2alpha activation and promoted osteochondrogenic differentiation of tendon stem/progenitor cells (TSPCs). Abnormal upregulation of HIF-2alpha served as a key switch to direct TSPCs differentiation into osteochondral-lineage rather than teno-lineage. Notably, Scleraxis (Scx), an essential tendon specific transcription factor, was suppressed on constitutive activation of HIF-2alpha and mediated the effect of HIF-2alpha on TSPCs fate decision. Moreover, pharmacological inhibition of HIF-2alpha with digoxin, which is a widely utilized drug, can efficiently inhibit calcification and enhance tenogenesis in vitro and in the Achilles's tendinopathy model. Taken together, these findings reveal the significant role of the tissue stem/progenitor cells fate decision and suggest that pharmacological regulation of HIF-2alpha function is a promising approach for soft tissue calcification treatment. Stem Cells2016;34:1083-1096
KeywordHypoxia-inducible Factors Vascular Calcification Arterial Calcification Extracellular-matrix Tendon Regeneration Cardiac-glycosides Human Tendinopathy Scleraxis Cartilage Inflammation
Indexed ByWOS:000374697700023
Language英语
Document Type期刊论文
Identifierhttps://ir.xtbg.ac.cn/handle/353005/10219
Collection文献共享
Recommended Citation
GB/T 7714
Hu, JJ,Yin, Z,Shen, WL,et al. Pharmacological Regulation of In Situ Tissue Stem Cells Differentiation for Soft Tissue Calcification Treatment[J]. STEM CELLS,2016,34(4):1083-1096.
APA Hu, JJ.,Yin, Z.,Shen, WL.,Xie, YB.,Zhu, T.,...&Ouyang, HW.(2016).Pharmacological Regulation of In Situ Tissue Stem Cells Differentiation for Soft Tissue Calcification Treatment.STEM CELLS,34(4),1083-1096.
MLA Hu, JJ,et al."Pharmacological Regulation of In Situ Tissue Stem Cells Differentiation for Soft Tissue Calcification Treatment".STEM CELLS 34.4(2016):1083-1096.
Files in This Item: Download All
File Name/Size DocType Version Access License
Pharmacological Regu(991KB) 开放获取CC BY-NC-SAView Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Hu, JJ]'s Articles
[Yin, Z]'s Articles
[Shen, WL]'s Articles
Baidu academic
Similar articles in Baidu academic
[Hu, JJ]'s Articles
[Yin, Z]'s Articles
[Shen, WL]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Hu, JJ]'s Articles
[Yin, Z]'s Articles
[Shen, WL]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: Pharmacological Regulation of In Situ Tissue Stem Cells Differentiation for Soft Tissue Calcification Treatment.pdf
Format: Adobe PDF
This file does not support browsing at this time
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.